Trial Profile

A phase I pharmacokinetic study of NATESTO testosterone nasal gel in male patients with seasonal allergic rhinitis

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Apr 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Testosterone (Primary)
Indications Hypogonadism
Focus Pharmacokinetics

Most Recent Events

04 Apr 2017 Results from this and NCT01446042 study investigating the impact of seasonal allergies on absorption of Natesto nasal gel in hypogonadal men, presented at The 99th Annual Meeting of the Endocrine Society.
07 Jul 2016 New trial record
17 Jun 2016 Results published in an Acerus Pharmaceuticals Corporation media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com